323 related articles for article (PubMed ID: 16401734)
1. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
Imitola J; Chitnis T; Khoury SJ
Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
Charil A; Filippi M
J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
4. [A critical review of the current pathogenesis of multiple sclerosis and possible future trends].
Casanova B; Burgal M; Coret F
Rev Neurol; 1999 May 1-15; 28(9):909-15. PubMed ID: 10390758
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis: a battle between destruction and repair.
McQualter JL; Bernard CC
J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
[TBL] [Abstract][Full Text] [Related]
6. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
[TBL] [Abstract][Full Text] [Related]
7. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
Owens T
Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
[TBL] [Abstract][Full Text] [Related]
8. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
9. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
Sindic CJ
Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of demyelination and tissue damage in multiple sclerosis.
Lassmann H
Acta Neurol Belg; 1999 Mar; 99(1):6-10. PubMed ID: 10218087
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
12. [Immunity and neurodegeneration: new concepts in multiple sclerosis].
Lalive PH; Schluep M; Chofflon M; Du Pasquier R
Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
Andrews HE; Nichols PP; Bates D; Turnbull DM
Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
[TBL] [Abstract][Full Text] [Related]
14. Early glial responses in murine models of multiple sclerosis.
Ayers MM; Hazelwood LJ; Catmull DV; Wang D; McKormack Q; Bernard CC; Orian JM
Neurochem Int; 2004; 45(2-3):409-19. PubMed ID: 15145555
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
Stadelmann C
Curr Opin Neurol; 2011 Jun; 24(3):224-9. PubMed ID: 21455066
[TBL] [Abstract][Full Text] [Related]
16. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
Hauser SL; Oksenberg JR
Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas O; Waiczies S; Zipp F
J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases.
Kerschensteiner M; Stadelmann C; Dechant G; Wekerle H; Hohlfeld R
Ann Neurol; 2003 Mar; 53(3):292-304. PubMed ID: 12601697
[TBL] [Abstract][Full Text] [Related]
19. Immunologic aspects of multiple sclerosis.
Boppana S; Huang H; Ito K; Dhib-Jalbut S
Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: is there neurodegeneration independent from inflammation?
Lassmann H
J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
